NCT Number: NCT00695357
Opinion of Patients Under Treatment That Meets the Criteria of New Treatment Strategy According to GINA 2006
Cross-sectional, one visit study. All the data will be collected through questionnaires. Descriptives statistics will be applied to the data. 832 patients will participate to the study and 104 physicians.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
Research Site, Aleksandroupoli, Greece
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patients diagnosed with persistent asthma (GINA 2005) for at least 6 months before entering the study
- Patients who are under treatment according to the new strategies described in GINA 2006 for at least 3 months before entering the study
Exclusion criteria
- Patients who are not willing to sign the Informed Consent Form
- COPD Patients
Treatment and study plan
Primary outcomes
-
Percentage (%) of Asthma treatment satisfaction and control grading
Time frame: single visit / once
Secondary outcomes
-
Rate of treatment compliance
Time frame: single visit / once
-
Patients quality of life under treatment
Time frame: single visit / once
Sponsors and collaborators
Lead sponsor
AstraZeneca
Industry
Registry information
Acronym: EPAGGELIA
Important dates
- Study start
- 2008
- Study completion
- 2008
- First posted
- Jun 11, 2008
- Registry last updated
- Apr 30, 2009
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.